RAB14 and osteosarcoma: Zhang et al. demonstrated that in plasma exosomes of osteosarcoma CASC15 is upregulated, and knockdown of CASC15 can inhibit osteosarcoma progression by targeting the miR-338-3p/RAB14 axis (Zhang et al., 2020b).